Access cutting-edge mct8 deficiency treatment through this clinical trial at a research site in Webster. Study-provided care at no cost to qualified participants.
Access mct8 deficiency specialists in Webster at no cost
This study follows strict safety protocols and ethical guidelines
All study-related mct8 deficiency treatment provided free
This is a double-blind, randomized phase 3 multicenter placebo-controlled study in at least 16 evaluable male participants diagnosed with MCT8 deficiency. Male participants, from 4 years of age (at randomization) and having demonstrated stable maintenance treatment with tiratricol, will be randomized to receive placebo or tiratricol for 30 days or until reaching rescue criterion (serum total triiodothyronine \[T3\] \> upper limit of normal \[ULN\] of the participant's normal range, for a sample
Sponsor: Rare Thyroid Therapeutics International AB
Check if you qualify for this mct8 deficiency clinical trial in Webster, TX
If you're searching for mct8 deficiency treatment options in Webster, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Webster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mct8 deficiency specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.